Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-89
SponsorVanderbilt University Medical Center
Among people living with HIV, heavy drinking increases the risk of heart disease and death. Studies suggest that alcohol changes the number and kind of bacteria in your gut and these changes increase the risk of heart disease and death. This randomized controlled trial will determine whether a pill containing healthy gut bacteria can increase the number good bacteria in the gut, lower levels of inflammation, and lower the risk of heart disease and death.
HIV infected
Not fluent in English
Vanderbilt University Medical Center
Lead sponsor
University of Louisville
Collaborator
Boston University
Collaborator